Alvorlige hududslæt, der kan ledsages af feber og/ eller forøgelser af transaminaser, er forekommet hos 0, 5% af PREZISTA- behandlede patienter.
Severe skin rash, which may be accompanied with fever and/ or elevations of transaminases, has occurred in 0.5% of patients treated with PREZISTA.